Comparing MTA and Biodentine for treating children's teeth
Official title: Clinical and Radiographic Success of Mineral Trioxide Aggregate (MTA) vs Septodont Biodentine in Primary Molars in Pulpotomy and Indirect Pulp Cap Treatments
Run by Geisinger Clinic · NCT04863222 · Data updated 2026-11-12
This study is testing whether two different treatments for children's tooth issues, MTA and Biodentine, work better for saving baby teeth in kids aged 2 to 12.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 2 Years to 12 Years |
| Sex | All |
| Enrollment | 646 (estimated) |
| Sponsor | Geisinger Clinic Academic / other |
| Locations | 1 site (Danville, Pennsylvania) |
| Status | Recruiting |
| Started | November 12, 2021 |
| Main results expected | August 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | December 23, 2025 |
| Trial ID | NCT04863222 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 2 to 12 with bilateral symptomatic or asymptomatic vital primary molars requiring pulpotomy or indirect pulp cap treatments.
✕Probably not a fit
Patients with irreversible pulpitis, necrotic pulp, or non-restorable molars will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective interventional study aims to evaluate the clinical and radiographic success of two medicaments, mineral trioxide aggregate (MTA) and Biodentine, in vital pulp therapy for primary molars in children aged 2 to 12. The study employs a randomized split-mouth design, where each child will receive one treatment on one side of their mouth and the other treatment on the opposite side. Participants will be monitored for clinical and radiographic outcomes every six months for three years following the procedures. The research is conducted in accordance with the standards set by the American Academy of Pediatric Dentistry at Geisinger Medical Center and Geisinger Bloomsburg Hospital.
Why it matters
Potential benefit: If successful, this study could provide a more cost-effective and less discoloring alternative to MTA for vital pulp therapy in children.
How similar studies have gone: While there is limited research on Biodentine, the study's approach of comparing it with MTA in pediatric dental care is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female patients ages of 2 to ≤12 years. * Bilateral symptomatic or asymptomatic vital primary molars with caries approximating or into the pulp. * Patient who need a pulpotomy and/or indirect pulp cap treatments in two or more quadrants. * Parents of patients who can provide consent in English. * Patients who need treatment in an operating room setting at Geisinger. Exclusion Criteria: * Pre-operative radiographic or clinical symptoms associated with irreversible pulpitis or necrotic pulp. * Radiographs not displaying furcation region of the tooth. * Patients with cardiac conditions who need prophylaxis for infective Endocarditis. * Patients with any type of cancer in the past or present. * Non-restorable molars.
Where it's running
-
Geisinger
Danville, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Gayatri Malik, DMD — Geisinger Clinic
- Study coordinator: Gayatri Malik, DMD
- Email: gmalik1@geisinger.edu
- Phone: 570-271-6355
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing stainless steel and zirconia crowns for children's teeth
This study is testing whether stainless steel crowns or zirconia crowns work better and make parents happier for kids aged 4 to 5 who need dental crowns on their back teeth.
-
Evaluating a new pulp treatment for children's primary molars
This study is testing a new dental treatment for kids aged 4 to 9 to see if a special material called Neo-Putty® works better than the usual method for saving their baby teeth.
-
Peer recovery support to help people stay on medication for opioid use disorder
This project will see if meeting with trained peer recovery supporters helps people with opioid use disorder stay on their medication treatment.
-
Informing low-acuity ED patients about non-emergency care options
This project will test whether sending a text message and adding information to your after-visit summary helps adults discharged from the ED with low-acuity visits use primary care or an intelligent triage tool instead of returning to the emergency department.
-
Angiography versus electrogram guidance for Bachmann bundle pacemaker lead placement
This study will try two ways to guide placement of an atrial pacemaker wire in the Bachmann bundle for people getting a permanent pacemaker or ICD to see which method leads to more successful placement.
-
Nurse follow-up nudge to reduce emergency visits after ambulatory-sensitive diagnoses
This project will test whether a nurse follow-up message or phone call after a clinic visit can reduce emergency department visits among adults (30+) diagnosed with ambulatory sensitive conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.